Quality Improvement Initiative Can Cut NTSV Cesarean Rate

Share this content:
Quality Improvement Initiative Can Cut NTSV Cesarean Rate
Quality Improvement Initiative Can Cut NTSV Cesarean Rate

MONDAY, Jan. 30, 2017 (HealthDay News) -- Quality improvement initiatives, including provider education and feedback, can reduce the nulliparous term singleton vertex (NTSV) cesarean delivery rate, according to a study published in the February issue of The Joint Commission Journal on Quality and Patient Safety.

From 2008 to 2015, Mary A. Vadnais, M.D., M.P.H., from Harvard Medical School in Boston, and colleagues used a multi-center approach that included provider education and feedback and implementation of new policies to target evidence-based and inferred factors that influence the NTSV cesarean delivery rate. Mode of delivery and maternal and neonatal outcomes data were obtained from birth certificates and administrative claims data.

The researchers analyzed more than 20,000 NTSV deliveries, including more than 15,000 during the intervention period. Over eight years, the NTSV cesarean delivery rate decreased from 35 to 21 percent. There was also a decline in the total cesarean delivery rate. There were increases in meconium aspiration syndrome and maternal transfusion.

"Quality improvement initiatives can decrease the NTSV cesarean delivery rate," the authors write. "Any increased incidence of fetal or maternal complications associated with decreased NTSV cesarean delivery rate should be considered in the context of the risks and benefits of vaginal delivery compared to cesarean delivery."

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »